Capstone Therapeutics ( (CAPS) ) just unveiled an announcement.
Capstone Holding Corp. reported an 8% year-over-year increase in Q4 2024 revenue and announced the successful launch of its Toro Stone brand in six new states. The company aims to achieve a $100 million revenue run rate and $10 million Adjusted Instone EBITDA by the end of 2025, focusing on strategic acquisitions to double its business size. Capstone’s efforts to expand its geographic footprint and strengthen its portfolio of proprietary brands are positioning it as a leading national platform in the building products industry.
More about Capstone Therapeutics
Capstone Holding Corp. is a building products distribution company that has expanded its business both organically and through strategic acquisitions. It operates in 31 US states and focuses on providing a value-added platform for acquisitions, with over half of its revenue derived from brands it owns or controls. The company’s product offerings include stone veneer, landscape stone, and modular masonry fireplaces.
YTD Price Performance: -12.36%
Average Trading Volume: 791,090
Technical Sentiment Signal: Buy
Current Market Cap: $12.51M
For a thorough assessment of CAPS stock, go to TipRanks’ Stock Analysis page.